Endocrine Abstracts

Background: The National Paediatric Diabetes Audit has identified inequalities in diabetes care. Children and young people (CYP) with Type 1 Diabetes Mellitus (T1DM) from both ethnic minority backgrounds and deprived areas are more likely to have reduced access to diabetes technologies and a higher HbA1c. In our service there was an inconsistent approach to the initiation of Continuous Glucose Monitoring (CGM) and use of insulin pumps. The introduction of a st...

Devices such as continuous glucose monitoring systems and insulin pumps are being increasingly used, improving quality of life and diabetic control for those with Type 1 diabetes mellitus. Skin reactions can occur at the local site which could be allergic, irritant or infective in nature. The history is key in differentiating between these. Typically infective or irritant dermatitis tend to cause intermittent problems and may start within days of a new device being applied to ...

The National Institute for Health and Care Excellence (NICE) recommends continuous glucose monitoring devices (CGMDs) for all adults and children with Type 1 diabetes mellitus (T1DM). Automated technologies such as hybrid closed loop (HCL) systems can improve outcomes and quality of life for patients, their families and carers. There have been increasing reports of cutaneous allergic reactions to medical devices, including CGMDs, in the literature. These reactions are mostly t...